<DOC>
	<DOCNO>NCT02103608</DOCNO>
	<brief_summary>This clinical study determine efficacy safety Glide , hair removal photo-depilation device , remove facial hair . During first stage , subject perform 6 face treatment , two week apart . The treatment 's safety efficiency evaluate 4 week last treatment 12 week last treatment .</brief_summary>
	<brief_title>Clinical Evaluation Silk ' n Glide Face</brief_title>
	<detailed_description>Study efficacy assessment : Comparison hair count treatment 4 12 week follow visit . Study safety assessment : 1 . Reported error near error use device 2 . Device malfunction relate device safety 3 . Device related adverse event 4 . Non device relate adverse event ( secondary endpoint )</detailed_description>
	<mesh_term>Hirsutism</mesh_term>
	<criteria>1 . Presence unwanted hair face 2 . Skin Type I IV ( Fitzpatrick ) 3 . Adults old 21 year age 60 year age . 4 . Must either postmenopausal surgically sterilize , use medically acceptable form birth control ( i.e. , oral contraceptive , IUD , contraceptive implant , barrier method spermicide abstinence ) . 5 . Informed consent agreement subject . 6 . Willingness follow treatment schedule post treatment care . 1 . Malignant premalignant pigment lesion area treat . 2 . Scarring infection area treat . 3 . Known photosensitivity . 4 . Pregnancy lactate 5 . Subjects Diabetes ( Type I II ) . 6 . Presence suntan area treat . 7 . Use medication know induce photosensitivity . 8 . Subject anticoagulative medication thromboembolic condition . 9 . Subjects pacemaker internal defibrillator . 10 . Use NSAIDS two week prior , two week follow treatment . 11 . Subjects use wax method photoepilation 3 month prior treatment . 12 . Subjects expose strong sunlight artificial tanning machine past 4 week 13 . Subjects wear tattoo permanent makeup area treat 14 . Subjects dark brown black spot , large freckle , birth mark , mole warts area treat 15 . Subjects Eczema , psoriasis , lesion , open wound active infection , cold sore area treat 16 . Subjects history keloidal scar formation 17 . Subjects history herpes outbreaks area treatment , unless consult physician receive preventative treatment use GlideTM 18 . Subjects epilepsy 19 . Subjects use incontinence device , insulin pump , active device [ NB : Protocol exclude pacemaker internal defibrillator . ] 20 . Subjects history skin cancer area potential skin malignancy 21 . Subjects receive radiation therapy chemotherapy treatment within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Home Photo depilation device , Silk ' n .</keyword>
</DOC>